@article{article, title  = {{MCL-509 Indirect Comparison of Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/s2152-2650(24)01602-1 }},

 year = {{2024}},

 month = {{9}},

 author = {{Shah B and Challagulla S and Xu S and Williams R and Ren S and Srivastava T and Gautam R and Yang K}},

 doi = {{10.1016/s2152-2650(24)01602-1}},

 volume = {{24}},

 journal = {{Clinical Lymphoma Myeloma and Leukemia}},

 pages = {{S516-S517}},

 note = {{Accessed on 2025/04/07}}}